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ABSTRACT
Objectives To investigate the association between
change in daily step count and both adiposity and insulin
sensitivity and the extent to which the association
between change in daily step count and insulin sensitivity
may be mediated by adiposity.
Design Population based cohort study.
Setting Tasmania, Australia.
Participants592 adults (men (n=267),mean age 51.4 (SD
12.2) years; women (n=325), mean age 50.3 (12.3) years)
who participated in the Tasmanian component of the
national AusDiab Study in 2000 and 2005.
Main outcome measures Body mass index, waist to hip
ratio, and HOMA insulin sensitivity at follow-up in 2005.
Results Over the five year period, the daily step count
decreased for 65% (n=382) of participants. Having a
higher daily step count in 2005 than in 2000 was
independently associated with lower body mass index
(0.08 (95% confidence interval 0.04 to 0.12) lower per
1000 steps), lower waist to hip ratio (0.15 (0.07 to 0.23)
lower), and greater insulin sensitivity (1.38 (0.14 to 2.63)
HOMA units higher) in 2005. The mean increase in HOMA
units fell to 0.34 (−0.79 to 1.47) after adjustment for body
mass index in 2005.
Conclusions Among community dwelling, middle aged
adults, a higher daily step count at five year follow-up
than at baseline was associated with better insulin
sensitivity. This effect seems to be largely mediated
through lower adiposity.
INTRODUCTION
Recent increases in type 2 diabetes and obesity in
many countries, including the United States and Aus-
tralia, have been partly attributed to declines in physi-
cal activity.1 Randomised controlled trials have shown
that interventions involving physical activity reduce
body mass index and the progression to insulin resis-
tance, but most were done in selected groups, such as
people with impaired glucose tolerance, or had com-
posite interventions including diet as well as physical
activity.2-5
Data from cohort studies relying onmeasurement of
physical activity by questionnaires strongly support an
independent role for physical activity. In a reviewof 10
cohort studies with follow-up ranging from 5 to
17 years, self reported regular physical activity ofmod-
erate intensity, compared with being inactive, was
associated with a reduced risk of type 2 diabetes
(pooled relative risk 0.69, 95% confidence interval
0.58 to 0.83). Some of this association seemed to be
mediated through a beneficial effect of activity on
body mass index (body mass index adjusted pooled
relative risk 0.83, 0.76 to 0.90).6
The advent of objectivemeasures of physical activity
has enabledmore precise measurement of activity pat-
terns, thus minimising misclassification on this
exposure.7 Theoretically, this should lead to better esti-
mates of the association of physical activity with out-
comes of interest. However, the randomised trials and
cohort studies in which objective measures of physical
activity have been incorporated have failed to clearly
identify an effect on insulin sensitivity, despite evi-
dence for reduced body fatness. A systematic review
of eight randomised trials carried out before 2007
found that interventions based on use of a
pedometer,8 despite achieving a mean increase of
2183 steps per day, failed to produce any effects on
fasting plasma glucose. Similarly, in cohort studies,
use of a pedometer was associated with a 2490 step
increase but with no change in plasma glucose.8 Both
study typeswere of short duration; the trials had amed-
ian duration of 12weeks, and themedian for the cohort
studies was nine weeks. More recently, two larger
cohort studies involving 192 and 367 participants,
and objective measurement of physical activity, have
reported conflicting findings about the association of
moderate and vigorous activity, and sedentary time,
with insulin resistance.9 10
The aim of this study was to examine the relation
between change in physical activity (measured objec-
tively by pedometer and also by self reported question-
nairemeasures) over a fiveyear period andeachofbody
mass index, waist to hip ratio, and insulin sensitivity (as
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estimated by theHOMAinsulin sensitivity index) at the
end of the five years, in a large population based sample
of participants from the AusDiab study.11
METHODS
Participants
The AusDiab study estimated the national prevalence
of diabetes and related risk factors in 2000. Participants
came from a national sample of adults aged 25 years
and older from six states and theNorthern Territory in
2000. Methods and central findings from this large
cross sectional survey have been reported
elsewhere.11 12 In Tasmania, six census collection dis-
tricts were randomly sampled from the Tasmanian list,
based on the 1996 Australian census.Within these dis-
tricts, adults aged 25 years and over were invited to
participate, and 40% of those who completed a house-
hold questionnaire participated in the full survey (n=
1848).11 We excluded from this study 175 participants
who had diabetes mellitus in 2000, as assessed by an
oral glucose tolerance test. Of the remaining 1611 who
had a result from an oral glucose tolerance test in 2000,
we included the 592 participants who provided ped-
ometer data for two days in both 2000 and 2005 in
the analyses reported in this paper.7 All participants
gave their consent by signing a consent form.
Study measures
In both 2000 and 2005 the participants were invited to
attend a clinic, where anthropometric and other mea-
surements were collected as described below and a
venous blood sample was obtained. Instructions for
the use and return of the pedometer were provided.
Questionnaire assessment of recent physical activity time
In 2000 and 2005 participants used the activeAustralia
questionnaire to report the frequency and duration of
physical activity in the previous week.13 Physical activ-
ity was estimated from the time spent walking for
recreation or transport and doing non-domestic activ-
ity and the time spent doing moderate intensity and
vigorous non-work activity during the previous week.
These questions have been found to provide reliable
and valid estimates of adults’ physical activity.14 We
calculated aweighted sumof the responses (with vigor-
ous activity given double weighting) to quantify the
total hours of physical activity time.7
Objective assessment of physical activity with pedometer
The pedometer protocol has been previously
described.7 The pedometers used were the Omron
HJ-003 and Omron HJ-102, with regular checks for
accuracy of counts. Research staff demonstrated the
use, placement, and operation of the pedometer, and
the participants were then given printed instructions
and a diary to record daily steps.7 The summary mea-
sure used was the average daily number of steps over
two consecutive days. A previous study had reported
intraclass correlations (to quantify agreement) of
0.71-0.84 for any two days of recording, and two
consecutive days captured 89% of the variance of a
seven day recording period.15
Diet and other lifestyle and demographic attributes
Current smoking status and level of education were
determined from the questionnaire. Usual dietary
intake over the previous 12 months was assessed with
a self administered validated food frequency question-
naire developed by the Anti-Cancer Council of
Victoria.11 We calculated nutrient intake by multiply-
ing the frequency of food consumption by standard
portion weights to obtain daily food weights.16 We
then converted these to nutrient intakes based on the
NUTTAB 95 nutrient composition data.16 Alcohol
intake also came from the food frequency question-
naire and was incorporated into the calculation of
total energy intake (kJ/day).11 We classified higher
education as participants having completed a univer-
sity or technical college degree, and socioeconomic
status was measured by using thirds derived from the
Australian based socioeconomic indexes for area.17
Clinical examination
Height was measured to the nearest 0.5 cm without
shoes, and weight was recorded to the nearest 0.1 kg.
Waist circumference was measured half way between
the lower border of the ribs and the iliac crest on the
horizontal plane. Hip circumference was measured at
the widest point over the buttocks. For each of waist
and hip circumference, the average of two consecutive
measurements within 2 cm was recorded. Body mass
index was calculated as weight (kg)/height (m)2. Parti-
cipants were classified as normal weight (body mass
index <25), overweight (25-<30), or obese (≥30). We
used waist to hip ratio and body mass index as mea-
sures of adiposity.
Assessment of HOMA insulin sensitivity
Venous blood was collected after an overnight fast
(eight hours). Blood specimens were centrifuged on
site and transported daily to the central laboratory.
Serum samples for insulin were stored at −80°C until
assayed. In 2000 plasma glucose levels were deter-
mined by using an Olympus AU600 automated analy-
ser. Serum insulin was measured by using a human
insulin specific radioimmunoassay kit (Linco
Research, St Charles, MO), only for participants aged
over 35 in 2000 (n=527).18 In 2005 fasting plasma glu-
cose was measured by using a Roche Modular (Roche
Diagnostics, Indianapolis, IN, USA) with a spectro-
photometric hexokinase method,18 and the laboratory
analysismethods in 2000 and2005were comparable.19
In 2005 serum insulin wasmeasured by using a chemi-
luminescence method for all participants. The homo-
eostatic model assessment of insulin sensitivity
(HOMA insulin sensitivity) was calculated by the
HOMA2 program.20 The HOMA model is the most
widely used surrogatemarker for assessing insulin sen-
sitivity and β cell function in clinical and epidemiolo-
gical studies.21
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Statistical analysis
We used Stata version 10.1 for all analyses. We use
numbers and percentages to describe categorical vari-
ables and means and standard deviations or medians
and interquartile ranges to describe quantitative vari-
ables. We used linear regression to describe the rela-
tion of each of the three outcomes (body mass index,
waist to hip circumference, and HOMA insulin sensi-
tivity) in 2005 with change between 2000 and 2005 in
each of pedometer measured and self reported physi-
cal activity measures in separate models (that is, six
separatemodels). For example, we used change in ped-
ometer measured activity (step count) as a continuous
predictor, adjusting for the corresponding pedometer
measured activity score (step count) in 2000, also in
continuous form. In addition to these “unadjusted”
analyses, we incorporated the potential baseline
(2000) confounders of age, sex, body mass index,
waist to hip ratio, HOMA insulin sensitivity, socioeco-
nomic status, total energy from all sources (kJ), current
smoking status, alcohol consumption (g/day), educa-
tion, and length of follow-up into adjusted models. In
addition, because insulin was measured slightly differ-
ently in 2005 and 2000, we did a supplementary ana-
lysis in which we analysed the ranks of the insulin
sensitivity scores in 2000 and 2005 in the adjusted
model rather than the actual values.
We tested modification of the effects of change in
pedometer measured and self reported physical activ-
ity on all three outcomes, examining sex and family
history of diabetes in 2000 as potential effectmodifiers.
For these analyses, we included product terms for the
interaction between change in activity and each of the
potential effect modifiers in regression models of the
outcomes.We also investigated whether effects of ped-
ometer measured physical activity on HOMA insulin
sensitivity were mediated through change in body
anthropometry, by adding body mass index in 2005
to the adjusted models and observing the resulting
change in estimates. In all models, we checked that
continuous covariates had linear relationswith the out-
comes, by using the method of fractional poly
nomials.22 We used normal probability plots to con-
firm that the residuals had a symmetrical distribution
and plots of the residuals against predicted values to
confirm an absence ofmarked deviation from constant
variance. As a sensitivity analysis, we fitted population
weighted models to determine whether the results
were influencedby differences in demographic charac-
teristics between the 592 participants analysed in this
study and the remaining participants from the Aus-
Diab cohort. We used weights that adjust the analysed
sample to be representative of the full AusDiab cohort
with respect to sex, age, and socioeconomic status in
2000. The weights were the inverse of the probability
of being analysed in this study, and we calculated them
by using the probabilities obtained after we fitted a
logistic regression of whether analysed in this study
(0=not analysed; 1=analysed) on sex, age, and socio-
economic status, using the full AusDiab cohort. Little
and Rubin have referred to this approach to handling
missing data of weighting the participants who provide
complete data as propensity weighting.23
We also examined the relation between pedometer
measured physical activity and the study outcomes by
using a categorical ordinal variable that summarises
the profile of change in objective physical activity.
We created the variable as follows. In both 2000 and
2005 we divided the study participants, by using tertile
defined cut-off points of the daily steps, into groups.
We classified participants who were in the lowest step
category in both 2000 and 2005 as persistent low steps
(lowest third at both waves) and those who dropped by
one or two categories between 2000 and 2005 as
decreasing steps (decline of one or two categories).
The other groups were persistent moderate steps (mid-
dle third at both waves), increasing steps (increase of
one or two categories), and persistent high steps (high-
est third at both waves). We tested for evidence of a
difference in means across the five groups. We report
the adjusted difference in the mean outcomes at 2005
between each category of step change and the persis-
tent low steps (reference) category.
RESULTS
Table1 shows the characteristicsof theparticipants.The
cohort observation period ranged from 4.8 to 5.0 years,
with a mean follow-up of 4.9 (SD 0.03) years. In 2000
Table 1 | Characteristics of cohort in 2000 and 2005. Values are mean (SD) unless stated otherwise
Characteristic
Baseline (2000) Follow-up (2005)
Men Women Men Women
Age (years) 51.4 (12.2) 50.3 (12.3) 56.3 (12.2) 55.3 (12.3)
Median (interquartile range) physical activity, by pedometer (steps/day) 10 172 (7435-13 928) 10969 (7889-14 402) 9108 (6261-11 792) 8700 (5843-11 963)
Median (interquartile range) physical activity in previous week, by questionnaire
(hours)
4.5 (2-9.5) 2.8 (0.8-6.5) 5.6 (2-11) 3.5 (1-8)
Waist circumference (cm) 95.5 (10.0) 82.5 (10.9) 98.3 (10.1) 85.6 (11.3)
Waist to hip ratio 0.94 (0.07) 0.81 (0.07) 0.94 (0.06) 0.81 (0.06)
Weight (kg) 83.8 (12.0) 68.3 (12.0) 85.1 (13.2) 69.9 (13.3)
Height (cm) 175.8 (6.7) 162.2 (6.0) 174.8 (6.8) 161.0 (6.1)
Body mass index (kg/m2) 27.1 (3.4) 26.0 (4.2) 27.8 (3.7) 26.9 (4.7)
Median (interquartile range) alcohol consumption (g/day) 12 (3-28) 2 (0-11) 13 (3-28) 3 (0-11)
Percentage (No) smokers 14.8 (39/263) 11.8 (38/322) 11.2 (29/259) 10.6 (33/311)
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the mean age was 51.4 (12.2) years for men and 50.3
(12.3) for women. A high proportion of participants
were overweight or obese in 2000 (men: 57.4% (152/
265) overweight and 17.7% (47/265) obese; women:
36.9% (120/325) overweight and 16.0% (52/325)
obese). The mean body mass index was 27.1 (3.4) for
men and 26.0 (4.2) for women. A further increase in
weight occurred over the five year period, as well as a
decline in daily step activity. Table 2 shows that
although most participants had a decline in steps over
time, more than a third had more daily steps by 2005,
and 16.7% stayed in the persistent high steps category.
We compared participants analysed here (n=592)
with the AusDiab participants in Tasmania without
diabetes in 2000 who were not analysed (n=1050).
The two groups were similar in age (mean 50.8 (SD
12.3) v 50.5 (15.2)), proportion of men (45.1% v
45.3%), weight (mean 75.3 (14.2) kg v 76.3 (16.3) kg),
and height (mean 168.3 (9.3) cm v 168.3 (9.5) cm). The
proportion of obese participants was slightly lower
among those analysed in this study (16.8% v 20.9%).
In 2000 a positive association existed between aver-
age daily step count and self report of walking/moder-
ate activity (Pearson’s r=0.21; P<0.001) and also a
weaker association with self reported vigorous activity
(r=0.13; P=0.001). The corresponding correlations
with average daily step count in 2005 were r=0.22
(P<0.001) for walking/moderate activity and r=0.12
(P=0.005) for vigorous activity. In 2005 the mean
HOMA insulin sensitivity was 108.0 (62.6) units for
men and 120.4 (61.8) units for women.
Relation between physical activity and outcomes in 2005
The fractional polynomials analysis showed that the
variables measuring activity in 2000 and change in
activity had linear relations with the three study out-
comes in 2005. We found generally strong evidence,
in the unadjusted and adjusted analyses, that both
higher daily steps in 2000 and higher daily steps in
2005 than in 2000 were associated with a lower body
mass index (table 3), a lowerwaist to hip ratio (table 4),
and greater insulin sensitivity in 2005 (table 5) when
we considered both simultaneously in a joint predic-
tion model. The tables show the adjusted results. In
the supplementary adjusted analysis in which we
examined the ranked insulin sensitivity scores, higher
daily steps in 2000 and higher daily steps in 2005 than
in 2000 were associated with greater HOMA insulin
sensitivity in 2005 (both P=0.03). Reported physical
activity timewas also generally associatedwith the out-
comes. In addition, higher reported physical activity in
2000 and higher physical activity in 2005 than in 2000
were associated with a lower body mass index and
greater insulin sensitivity in 2005 when both were con-
sidered simultaneously in a joint prediction model.
The estimates, if they correspond to causal effects,
would imply the following quantitative results. If a rela-
tively inactive person increased his or her daily steps
by 10 000 a day,24 the resultant change would be a
decrease in body mass index of 0.83 units. The resul-
tant 13.85 unit improvement in HOMA insulin sensi-
tivity represents a 12.8% increase from the population
mean values for men and an 11.5% increase for
women. For a relatively inactive person increasing
thenumber of steps by 2000 aday (similar to aprevious
recommendation of 3000 steps a day for five days25),
the resultant changes would be a decrease of 0.16 units
for bodymass index and an improvement of 2.76 units
for HOMA insulin sensitivity, after adjustment for the
factors listed in the footnote of table 3.
Tests of interaction showed little evidence that the
effects of the physical activity measures are modified
by sex and family history of diabetes (data not shown).
In addition, the effect of a change in steps on bodymass
index, waist to hip ratio, andHOMA insulin sensitivity
in 2005 did not vary according to average daily steps in
2000.
Table 2 | Changes in daily steps activity over time (n=592)
Change in activity % (No) participants in each category
Average steps/day, 2000-5
Decrease >3000 37.2 (220)
Decrease 1000-3000 18.8 (111)
Decrease 1-1000 8.6 (51)
Increase 0-1000 8.3 (49)
Increase 1000-3000 14.0 (83)
Increase >3000 13.2 (78)
Step change category*
Persistent low steps 18.4 (109)
Decreasing steps 26.5 (157)
Persistent moderate steps 12.0 (71)
Increasing steps 26.4 (156)
Persistent high steps 16.7 (99)
*Persistent low steps=lowest third at both waves; decreasing
steps=decline of 1 or 2 thirds; persistent moderate steps=middle third at
both waves; increasing steps=increase of 1 or 2 thirds; persistent high
steps=lowest third at both waves.
Table 3 | Association between indicators of physical activity level at baseline, change in levels between 2000 and 2005, and
body mass index in 2005
Exposures used in separate models Mean change* (95% CI) P value
Average daily steps in 2000, by pedometer (per 1000 higher per day) −0.06 (−0.10 to −0.02) 0.01
Change in average daily steps 2000-5, by pedometer (per 1000 higher per day) −0.08 (−0.12 to −0.04) <0.001
Total physical activity time in 2000, by questionnaire (per 1 hour higher per week) −0.04 (−0.07 to −0.004) 0.03
Change in total physical activity time 2000-5, by questionnaire (per 1 hour higher per week) −0.07 (−0.10 to −0.04) <0.001
*Adjusted for age, sex, body mass index in 2000, socioeconomic status in 2000, total energy intake from all sources (kJ) in 2000, smoking status in
2000, alcohol consumption (g/day) in 2000, education in 2000, and length of cohort follow-up. Note that separate models were fitted for each type
of activity (exposure).
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The results of further analyses suggested that the
apparent effect of higher step activity on enhanced
HOMA insulin sensitivity was largely mediated
through the change in adiposity; the adjusted regres-
sion coefficient for change in steps dropped from 1.38
to 0.34 (95% confidence interval −0.79 to 1.47; P=0.56)
after adjustment for body mass index in 2005. The
addition of bodymass index in 2005 reduced the mag-
nitude of the regression coefficient between change in
steps and insulin sensitivity by 75%.
When we weighted the regression analyses to allow
for potential loss to follow-up, taking account of the
composition of the entire group of AusDiab partici-
pantswithout diabetes in our region in 2000, the results
were similar to those of the main analysis (data not
shown). This suggests that no loss to follow-up bias
exists related to lack of representativeness on the vari-
ables used to calculate the weights.
Relation of profile of change in steps between 2000 and
2005 with outcomes
To gain further insights into the effect of changing ped-
ometer steps over time, we examined the association of
the ordinal variable describing change in steps in rela-
tion to the study outcomes. The figure summarises the
adjusted differences between the persistent low steps
category (reference) andeachof theother four categories
with respect tomean outcome in 2005. Participants who
maintained a persistently high step count between 2000
and2005hadameandifferenceof−0.82 (−1.39 to−0.26)
bodymass index units and 16.85 (0.13 to 33.57) units of
HOMA insulin sensitivity in 2005, relative to those who
had persistently low step counts.
DISCUSSION
In this large population based cohort, a higher step
activity at the end of a five year follow-up period than
at the beginningwas associatedwith a lower bodymass
index, lower waist to hip ratio, and higher HOMA
insulin sensitivity at the five year follow-up. The
observed association of step activity with enhanced
HOMA insulin sensitivity was largely accounted for
by bodymass index in 2005. This may indicate a med-
iation effect through change in body mass index. This
finding is consistent with data from cohort studies that
have used self reported measures of physical activity.6
This study enabled us to examine the association of the
change in each of the pedometer steps and question-
naire measures of physical activity with obesity and
insulin sensitivity, while adjusting for other lifestyle
determinants such as diet, alcohol, and smoking.
Comparison with other studies
Participants who had a high daily step count at both
2000 and five years later had a lower body mass
index (0.8 less) and higher HOMA insulin sensitivity
(16.9 units higher) relative to those who had persis-
tently low step count from 2000 to 2005. Our estimate
of the independent association of steps with bodymass
index (0.16 lower body mass index for an increase of
2000 steps) was lower than the 0.38 previously
reported as the summary effect of pedometer use asso-
ciated with a 2000-2500 change in steps.8 This may
reflect the fact that many previous studies involved
interventions to increase pedometer use,8 and other
associated effects such as a greater awareness of energy
balance and thus caloric restrictionmayhave beenpre-
sent. We focused on a higher daily step activity,
although most participants had a decline in step activ-
ity, to provide parallel results to those that would be
available from interventions involving physical activ-
ity in this area.
Strengths and limitations
The major strengths of this study are its size, duration,
and objective measure of physical activity and the
Table 4 | Association between indicators of physical activity level at baseline, change in levels between 2000 and 2005, and
waist to hip ratio in 2005
Exposures used in separate models Mean change* (95% CI) P value
Average daily steps in 2000, by pedometer (per 1000 higher per day) −0.13 (−0.21 to −0.05) 0.003
Change in average daily steps 2000-5, by pedometer (per 1000 higher per day) −0.15 (−0.23 to −0.07) <0.001
Total physical activity time in 2000, by questionnaire (per 1 hour higher per week) −0.05 (−0.12 to 0.02) 0.16
Change in total physical activity time 2000-5, by questionnaire (per 1 hour higher per week) −0.09 (−0.15 to −0.04) 0.002
*Adjusted for age, sex, waist to hip in 2000, socioeconomic status in 2000, total energy intake from all sources (kJ) in 2000, smoking status in 2000,
alcohol consumption (g/day) in 2000, education in 2000, and length of cohort follow-up. Note that separate models were fitted for each type of
activity (exposure).
Table 5 | The association between indicators of physical activity level at baseline, change in levels between 2000 and 2005,
and HOMA insulin sensitivity in 2005
Exposures used in separate models Mean change* (95% CI) P value
Average daily steps in 2000, by pedometer (per 1000 higher per day) 1.72 (0.45 to 2.99) 0.01
Change in average daily steps 2000-5, by pedometer (per 1000 higher per day) 1.38 (0.14 to 2.63) 0.03
Total physical activity time in 2000, by questionnaire (per 1 hour higher per week) 1.35 (0.31 to 2.39) 0.01
Change in total physical activity time 2000-5, by questionnaire (per 1 hour higher per week) 1.27 (0.42 to 2.12) 0.004
*Adjusted for age, sex, HOMA insulin sensitivity in 2000, socioeconomic status in 2000, total energy intake from all sources (kJ) in 2000, smoking
status in 2000, alcohol consumption (g/day) in 2000, education in 2000, and length of cohort follow-up. Note that separate models were fitted for
each type of activity (exposure).
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outcomemeasures. Pedometer assessmentsweremade
on two occasions spanning a five year interval in more
than 500 people. In addition, at the same time points
we measured physical activity by questionnaire and a
range of other potential determinants of obesity.
In an observational study such as this, confounding
is always a possible explanation for observed associa-
tions. We were able to control for baseline age, sex,
body mass index, waist to hip ratio, HOMA insulin
sensitivity, socioeconomic status, total energy intake
from all sources (kJ), current smoking status, alcohol
consumption (g/day), education, and length of cohort
follow-up. Adjustment for these factors did not materi-
ally alter the estimate of association. Loss to follow-up
in a cohort study could also bias the results. We were
able to account for this by weighting the results for the
loss that occurred and found that this did not affect the
estimate of the association between change in steps and
insulin sensitivity. Further evidence supporting a pos-
sible causal connection is that these study results are
supported by evidence from randomised trials, at
least for body mass index, albeit over shorter time-
frames and with smaller numbers.
As we collected data only in 2000 and 2005, we
could not determine the exact timing of the change in
number of steps taken or the duration of any change.
We could only take the two measures as a summary
estimate of what happened over the five years. Never-
theless, both steps in 2000 and change in steps between
2000 and 2005were associatedwith a lower bodymass
index, a lower waist to hip ratio, and greater insulin
sensitivity in 2005.
The pedometermeasuresmovement only in the ver-
tical plane and thereforemost readily captures walking
or running type movements. It would miss activity in
the horizontal plane, such as cycling, but probably cap-
tures most of the activity undertaken by adults of this
age. Supporting this, it has been shown to be highly
associated with accelerometry, a more complex mea-
sure of total body movement. The correlation coeffi-
cient relating the two measures has been estimated at
0.74 to 0.86.26
We found only a modest association between the
objective and reported measures of physical activity.
This emphasises the importance of not relying on self
report alone because of potential non-differential mea-
surement error and reporting bias.
A guideline of 10 000 steps a day is approximately
equivalent to 5 miles (8 km) covered on foot,27 but the
actual energy expenditure will vary depending on age,
sex, height, leg length, and gait.28 An average woman’s
step length is 67 cmand that for aman is 76 cm,29mean-
ing that a woman walks a kilometre in 1493 steps and a
man in 1316 steps. If the energy equivalent of walking
1 km, based on the person’s body weight, is approxi-
mately 200 kJ of energy,30 then an increase of 2000
steps would equate to an added energy expenditure of
approximately 268 kJ for women and 304 kJ for men.
Conclusions and policy implications
These findings, confirming an independent beneficial
role of higher daily step count on body mass index,
waist to hip ratio, and insulin sensitivity, provide
further support to promote higher physical activity
levels among middle aged adults. The use of a ped-
ometer for measuring physical activity allows quantifi-
cation of the magnitude of these effects, in terms of
daily step activity, which should assist future public
health policy.
Our findings indicate that the relation between a
change in steps over time and the relevant outcomes
Change in steps category
B
od
y 
m
as
s 
in
de
x 
(p
er
 u
ni
t)
PLS DS PMS IS PHS
-1.5
-1.0
-0.5
0
0.5
W
ai
st
 to
 h
ip
 ra
ti
o 
(%
)
-3
-2
-1
0
1
In
su
li
n 
se
ns
it
iv
it
y 
(u
ni
ts
)
-10
0
10
20
40
30
Reference category (regression coefficient = 0)
Adjusted mean difference in body mass index (BMI), waist to
hip ratio (WHR), and HOMA insulin sensitivity in 2005 for each
category of step change compared with persistent low steps
category. Mean differences adjusted for age, sex,
socioeconomic status in 2000, total energy from all sources
(kJ) in 2000, smoking status in 2000, alcohol consumption
(g/day) in 2000, education in 2000, and length of cohort
follow-up. BMI in 2005 outcome additionally adjusted for BMI
in 2000, WHR in 2005 outcome additionally adjusted for WHR
in 2000, and HOMA insulin sensitivity in 2005 outcome
additionally adjusted for HOMA insulin sensitivity in 2000.
PLS=persistent low steps (lowest third at both waves);
DS=decreasing steps (decline of 1 or 2 categories);
PMS=persistent moderate steps (middle third at both waves);
IS=increasing steps (increase of 1 or 2 categories);
PHS=persistent high steps (lowest third at both waves). Test
of difference in mean outcomes across five groups: for BMI,
P=0.001; for WHR, P=0.03; for insulin sensitivity, P=0.09
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is linear in nature.On this basis,we estimate that, in our
setting, a sedentary person who takes a very low num-
ber of daily steps but who was able to change beha-
viour over five years to meet the popular 10 000 daily
step guideline would have a threefold improvement in
HOMA insulin sensitivity compared with a similar
person who increased his or her steps to meet the
more recent recommendation of 3000 steps for five
days a week.24 25
In conclusion, among community dwelling people,
an increase in physical activity over time, measured
objectively by pedometer, is associated with better
HOMA insulin sensitivity. This apparent beneficial
effect seems to be largely mediated through a change
in adiposity.
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